Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter and half year ended 30th September, 2025.
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals Limited has submitted to NSE the compliance certificate required under the SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter and half year ended 30th September, 2025. This is a routine regulatory filing that companies must submit to confirm the reconciliation of their share capital between physical and demat (electronic) forms with the depositories. The filing also typically includes confirmation from a practising company secretary about the proper handling of share transfers, transmissions, and other share-related activities during the period.
This is a standard compliance filing and does not indicate any change in business, financials, or shareholding. Investors should treat it as routine housekeeping with no material impact on the stock price.